AB Science has received a binding offer for a Clinical Trial Funding Insurance policy from Medical & Commercial International Ltd. (MCI), Lloyd's Syndicate 1902, for its Phase III clinical trial ...
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON ITS DEVELOPMENT PLAN AND FINANCIAL CALENDAR FOLLOWING A SPONSOR GOOD CLINICAL PRACTICE INSPECTION Confirmation of the relevance of having, among the ...
AB Science S.A. considered that its development plan will need to be adapted as follows: Step 2: Resumption of the phase 1 study in acute myeloid leukemia (compound AB8939) within the framework of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results